Eiken Chemical Co. Ltd. | Ownership

Companies that own Eiken Chemical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Matthews International Capital Management LLC
3,820,000
8.77%
561,200
0.25%
01/29/2018
FIL Investments (Japan) Ltd.
3,062,100
7.03%
-599,100
0.51%
03/30/2018
Asset Management One Co., Ltd.
2,809,000
6.45%
0
0.04%
03/31/2018
T. Rowe Price International Ltd.
2,024,600
4.65%
-802,800
0.08%
01/15/2018
Sumitomo Mitsui Asset Management Co., Ltd.
1,955,000
4.49%
-439,200
0.24%
01/31/2018
Norges Bank Investment Management
869,198
2%
139,398
0%
12/31/2017
The Vanguard Group, Inc.
732,900
1.68%
4,000
0%
07/31/2018
T. Rowe Price International Ltd. (Japan)
572,000
1.31%
102,500
0.76%
06/30/2018
Nomura Asset Management Co., Ltd.
551,098
1.27%
-388,300
0.01%
07/31/2018
Goldman Sachs Asset Management Co. Ltd. (Japan)
480,699
1.1%
36,999
0.56%
06/30/2018

About Eiken Chemical Co.

View Profile
Address
Yamaguchi Building, 7/F
Tokyo Tokyo 110
Japan
Employees -
Website http://www.eiken.co.jp
Updated 07/08/2019
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. It operates through Clinical Diagnostics and Testing of Food and Environment business divisions. The Clinical Diagnostics division handles the manufacture of clinical diagnostic products and services.